2017 version of the artificial organ market analysis

How will artificial organs continue to improve and transform organ transplants in the next 20 years? Half of the world's top ten causes of death will benefit from artificial organs For patients with end-stage organ failure such as liver, kidney and heart, organ transplantation is the only hope for treatment. Sadly, most patients wait until they die, and they can't get to the right organs. Therefore, for decades, the industry has been hoping to develop artificial organs composed of electronic and mechanical components. The first artificial heart transplant was born in the 1980s, but over the years, these artificial hearts have not improved much, making them more efficient. Newcomers to the field, Carmat and Bivacor, hope to change the current state of the artificial heart by using smarter solutions that embed sensors and software algorithms. At present, the trend of diabetes affecting every country in the world and 8% of the world's population will bring about a new round of development of artificial organs. In this context, the compound annual growth rate (CAGR) of the artificial pancreas market is expected to reach 49% in the next five years, and the market size will grow to $1.3 billion by 2022.

The artificial blood vessel market and development route forecast for 2016~2040 The next round of breakthroughs in the artificial organ field is expected to bring artificial lungs and artificial kidneys in the next 5 to 10 years. The first certified commercial artificial organ will be a wearable system such as the Wearable Artificial Kidney Foundation, Inc. (WAKFI) wearable artificial kidney system. After that, we will soon see portable artificial organs, such as the artificial transplant organs developed by the University of California, San Francisco and Vanderbilt University's kidney project. In addition to accessibility, artificial organs also include many other advantages, such as fewer biocompatibility issues, eliminating the ethical issues of organ trafficking and, of course, reducing the cost of transplantation. In 2017, the artificial organ market is expected to be $1.3 billion, with a compound annual growth rate of 20% in the next five years and a growth of $3.5 billion by 2022. This report describes the market dynamics of artificial organs, manufacturers and technical challenges. Artificial heart and artificial pancreas are ready to detonate the artificial organ market. Bringing a new artificial organ to the market requires a long process and a lot of capital costs. Developing such a complex technology takes an average of 15 to 25 years, and it takes 5 to 10 years of testing and regulatory certification. Therefore, the long development cycle explains why artificial organs have such a huge market prospect, and only a few companies will invest in the development of artificial organs. If developers decide to commercialize this technology, investors need to be patient. According to Memes Consulting, ventricular assistive medical devices have become more mature markets, with industry giants such as Abbott and Medtronic, which have acquired two leading companies in the field - Thoratec and HeartWare. the company. However, the fully artificial heart market is still an emerging field, and Syncardia has been the only manufacturer in the field for many years. With the addition of newcomers, the fully artificial heart market will achieve a CAGR of 15% during the forecast period.

Artificial organs: development cycle and funding sources Type 1 diabetes populations have long been waiting for artificial pancreas solutions, so we expect market penetration of artificial pancreas to quickly increase. In 2017, only Medtronic had an artificial pancreas system certified by the US Food and Drug Administration (FDA). However, no similar products have obtained EU CE certification. However, many vendors are already preparing for certification and commercialization, especially two alliances: one including Diabeloop, Dexcom and Cellnovo; the other includes TypeZero, Dexcom and Tandem. After decades of research and development, artificial organ products are now ready for entry into the medical device market. In this report, Yole explains the upcoming artificial organ revolution in the next few years with a unique perspective. Artificial organs have evolved from the past mechanical components to the current electronic, and in the future they will become more intelligent. You must have seen the movie of "Superman" theme. Perhaps everyone has talked about whether they will choose to replace Superman's lungs, or eternal self-supplied energy. heart. You and your friends may have different opinions on the choices, but after some debate, you will definitely think that this idea is still far away. It now appears that this vision may be realized in the next few years. Today's artificial organs contain only a few sensors. However, in the near future, the next generation of artificial organs will embed a large number of sensors to detect the signs of patients, and will add artificial intelligence to cope with changes in physiological parameters.

The type and context of artificial organ embedded software to control the software of these artificial organs must be synchronized with engineering development. At present, especially for artificial pancreas, many different algorithms have been developed, each of which has advantages and disadvantages, but all have inherent control laws. They span a very simple binary answer, as well as a complex combination of data from sensors, physical laws, and precise output calculations, all embedded in a complex, fast algorithm. The next generation of algorithms is under development and we are looking forward to greater improvements. New and fashionable solutions, such as machine learning and deep learning, will be studied by fuzzy logic algorithms when the required data is available. These programs should be promising and enable full automatic control of artificial organs. This report describes a number of different algorithms in artificial pancreas and fully artificial hearts. This report also introduces technologies that help the development of artificial organs, such as biocompatibility, batteries and sensors.